BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9650218)

  • 1. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].
    Ostwald E; Sabri O; Cremerius U; Jakse G; Büll U
    Nuklearmedizin; 1999; 38(7):302-5. PubMed ID: 10599071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
    Rudberg U; Udén R; Ahlbäck SO
    Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
    Otsuka N; Fukunaga M; Morita R; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A
    Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
    Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
    Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology].
    Feggi LM; Spanedda R; Scutellari PN; Prandini N; Gennari M; Orzincolo C; Scapoli GL; Bagni B
    Radiol Med; 1988 Oct; 76(4):311-5. PubMed ID: 3141987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
    Haddock G; Gray HW; McKillop JH; Bessent RG; Kirk D
    Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma.
    Berná L; Germá JR; Estorch M; Torres G; Blanco R; Carrió I
    J Nucl Med; 1991 Dec; 32(12):2295-8. PubMed ID: 1836021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
    Bathmann J; Moser E
    Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF; Wollett FC
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-super bone scan caused by bone marrow involvement of prostate cancer.
    Seo Y; Shuke N; Yamamoto W; Usui K; Aburano T
    Ann Nucl Med; 1999 Oct; 13(5):351-4. PubMed ID: 10582806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
    Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
    Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance.
    Berná L; Torres G; Carrió I; Estorch M; Germá JR; Alonso C
    Clin Nucl Med; 1994 Feb; 19(2):121-8. PubMed ID: 8187396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of planar scintigraphy and MRI in the screening of skeletal metastases].
    Silit E; Başekim CC; Mutlu H; Pekkafali Z; Kizilkaya E; Karsli AF
    Tani Girisim Radyol; 2003 Sep; 9(3):357-61. PubMed ID: 14661604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.
    Roudier MP; Vesselle H; True LD; Higano CS; Ott SM; King SH; Vessella RL
    Clin Exp Metastasis; 2003; 20(2):171-80. PubMed ID: 12705638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiologic diagnosis of bone metastases recurrence in patients with prostate cancer treated strontium-89].
    Barysheva EV; Selivanov SP; Riannel' IuE; Velichko SA; Usynin EA; Usov VIu
    Vestn Rentgenol Radiol; 1999; (5):32-6. PubMed ID: 12717923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoplastic bone metastases in prostatic carcinoma: magnetic resonance tomography and bone marrow scintigraphy].
    Venz S; Hosten N; Friedrichs R; Neumann K; Cordes M; Nagel R; Felix R
    Rofo; 1994 Jul; 161(1):64-9. PubMed ID: 8043767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.